HGR 19.88 Hanger Orthopedic Group $HGR Hit a 52 week low of

New Post Public Reply Private Reply Replies (0) Message Board
Emylers
HGR 19.88 Hanger Orthopedic Group $HGR Hit a 52 week low of 19.59 Currently at 19.88 -4.31 -17.82% With a day low of 19.59 and a total volume of 1,484,400.

HGR Hanger Orthopedic Group Recent Headline News

NYSE stocks posting largest percentage decreases
AP - Fri Nov 07, 5:08PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on New York Stock Exchange at the close of trading:
PNK: 22.85 (-0.37), CZZ: 9.42 (+0.08), PBH: 32.79 (-4.53), TCAP: 23.47 (+0.96), MED: 29.77 (-3.04), AMBR: 11.40 (-2.21), ANF: 29.50 (-5.88), NSM: 29.83 (+1.96), NKA: 5.41 (-0.54), GNW: 8.41 (-0.25), HGR: 19.88 (-4.31), KOP: 32.47 (+0.25)

Hanger to Reschedule Third Quarter 2014 Earnings Release and Conference Call
PR Newswire - Thu Nov 06, 3:12PM CST
Hanger, Inc. (NYSE: HGR) announced today that it is rescheduling the release of its third quarter 2014 earnings and related earnings conference call to allow additional time for the completion and review of its third quarter financial statements. The Company expects to reschedule the call to occur the week of November 10th, and will issue a press release with the specific date prior to the event.
HGR: 19.88 (-4.31)

Hanger Orthopedic Down 29.2% Since SmarTrend Downtrend Call (HGR)
Comtex SmarTrend(R) - Tue Nov 04, 9:15AM CST
SmarTrend identified a Downtrend for Hanger Orthopedic (NYSE:HGR) on March 24th, 2014 at $33.54. In approximately 8 months, Hanger Orthopedic has returned 29.21% as of today's recent price of $23.74.
HGR: 19.88 (-4.31)

Hanger Orthopedic Down 33.1% Since SmarTrend Downtrend Call (HGR)
Comtex SmarTrend(R) - Mon Oct 27, 4:50PM CDT
SmarTrend identified a Downtrend for Hanger Orthopedic (NYSE:HGR) on March 24th, 2014 at $33.54. In approximately 7 months, Hanger Orthopedic has returned 33.11% as of today's recent price of $22.43.
HGR: 19.88 (-4.31)

34.3% Return Seen to Date on SmarTrend Hanger Orthopedic Call (HGR)
Comtex SmarTrend(R) - Mon Oct 20, 11:01AM CDT
SmarTrend identified a Downtrend for Hanger Orthopedic (NYSE:HGR) on March 24th, 2014 at $33.54. In approximately 7 months, Hanger Orthopedic has returned 34.34% as of today's recent price of $22.02.
HGR: 19.88 (-4.31)

Hanger to Release Third Quarter 2014 Results on Thursday, November 6 After Market Close and Host Conference Call at 9:00 am Eastern on Friday, November 7
PR Newswire - Fri Oct 17, 4:00PM CDT
Hanger, Inc. (NYSE: HGR) announced today that it plans to report its results of operations for the quarter ended September 30, 2014, on Thursday, November 6, 2014 after the market closes. A conference call to discuss these results is scheduled to begin at 9:00 a.m., ET, on Friday, November 7, 2014. Those wishing to participate should call 1-877-662-6095. A replay will be available until Friday, November 14, 2014 by dialing 1-855-859-2056 and referencing Conference ID # 91880739.
HGR: 19.88 (-4.31)

Hanger Orthopedic Has Returned 37.8% Since SmarTrend Recommendation (HGR)
Comtex SmarTrend(R) - Mon Oct 13, 9:30AM CDT
SmarTrend identified a Downtrend for Hanger Orthopedic (NYSE:HGR) on March 24th, 2014 at $33.54. In approximately 7 months, Hanger Orthopedic has returned 37.80% as of today's recent price of $20.86.
HGR: 19.88 (-4.31)

Hanger Underperforms on Falling Earnings and Guidance - Analyst Blog
Souvik Guha - Zacks Investment Research - Mon Sep 29, 12:50PM CDT
Hanger (HGR) posted first-quarter adjusted earnings of 19 cents per share, down 29.6% from the year-ago level of 27 cents.
ICUI: 71.16 (-0.89), SMA: 9.27 (-0.21), HGR: 19.88 (-4.31), HSP: 56.32 (-0.32)

Downtrend Call Working As Hanger Orthopedic Stock Falls 37.4% (HGR)
Comtex SmarTrend(R) - Fri Sep 26, 4:45PM CDT
SmarTrend identified a Downtrend for Hanger Orthopedic (NYSE:HGR) on March 24th, 2014 at $33.54. In approximately 6 months, Hanger Orthopedic has returned 37.44% as of today's recent price of $20.98.
HGR: 19.88 (-4.31)

Hanger Orthopedic Shares Down 33.2% Since SmarTrend's Sell Call (HGR)
Comtex SmarTrend(R) - Fri Sep 19, 11:01AM CDT
SmarTrend identified a Downtrend for Hanger Orthopedic (NYSE:HGR) on March 24th, 2014 at $33.54. In approximately 6 months, Hanger Orthopedic has returned 33.17% as of today's recent price of $22.41.
HGR: 19.88 (-4.31)

Hanger announces Thomas Kiraly to become Chief Financial Officer
PR Newswire - Thu Sep 11, 3:10PM CDT
Hanger, Inc. (NYSE: HGR) today announced that Thomas Kiraly, former Executive Vice President, Chief Financial Officer, and Treasurer of Sheridan Healthcare, will join Hanger as Executive Vice President on Oct. 1 and will become Chief Financial Officer during the fourth quarter 2014. Mr. Kiraly will work closely with incumbent CFO George McHenry until Mr. Kiraly assumes the role of CFO later this year. As previously announced, Mr. McHenry will retire on Dec. 31, 2014.
HGR: 19.88 (-4.31)

Hanger Appoints Melissa Debes as Chief Accounting Officer
PR Newswire - Wed Sep 03, 3:05PM CDT
Hanger, Inc. (NYSE: HGR) today announced it has appointed Melissa Debes as Vice President and Chief Accounting Officer, effective September 8, 2014. Ms. Debes has served as Corporate Controller at Hanger since March 11, 2014.
HGR: 19.88 (-4.31)

Insider Trading Alert - RSG, HGR And URI Traded By Insiders
at The Street - Wed Aug 27, 9:30AM CDT
Stocks with insider trader activity include RSG, HGR and URI
RSG: 39.13 (+0.42), HGR: 19.88 (-4.31), URI: 113.39 (-0.37)

MedTech Defies Sequestration, M&As Steal the Show - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 3:31AM CDT
MedTech Defies Sequestration, M&As Steal the Show - Industry Outlook
ABMD: 32.13 (+0.47), BDX: 125.54 (-2.39), MDT: 68.10 (-0.64), ARAY: 6.85 (-0.05), NUVA: 41.75 (-0.18), CYBX: 50.30 (-0.90), BSX: 13.24 (-0.12), JNJ: 108.20 (-0.81), ICUI: 71.16 (-0.89), WMGI: 27.95 (-0.49), OPK: 8.32 (-0.10), RMD: 51.14 (-0.43), ABBV: 61.50 (-1.21), SYK: 87.47 (-1.08), ZMH: 108.19 (-2.00), ABT: 43.37 (-0.32), SMA: 9.27 (-0.21), BCR: 162.38 (-2.59), MCK: 199.32 (-3.34), TMO: 116.60 (-2.31), PFE: 29.92 (-0.12), COV: 92.08 (-0.52), EW: 122.76 (-0.81), MYL: 53.11 (-0.39), COO: 165.00 (-1.08), CG: 28.94 (+0.68), ABAX: 51.63 (-2.21), BAX: 70.61 (-0.99), DGX: 61.69 (-1.07), STJ: 64.76 (-1.28), THOR: 26.93 (+0.83), HGR: 19.88 (-4.31)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Zenas BioPharma Investors Urged to Join Class Action Lawsuit

Updated Category News Views 119

Overview of the Class Action Lawsuit Levi & Korsinsky, LLP is reaching out to investors in Zenas BioPharma, Inc. regarding a crucial class action lawsuit. This lawsuit may greatly impact those who have invested in Zenas BioPharma as it seeks to compensate individuals who have suffered losses due to alleged securities fraud. Understanding the Legal Landscape This class...

Continue Reading
Ayar Labs Raises $155 Million to Transform AI Infrastructure

Updated Category News Views 716

Ayar Labs Secures Significant Funding to Enhance AI Infrastructure Ayar Labs has recently secured $155 million in financing aimed at addressing the critical needs in AI infrastructure. With backing from prominent investors such as AMD Ventures, Intel Capital, and NVIDIA, alongside Advent Global Opportunities and Light Street Capital, this investment elevates the total...

Continue Reading
Transforming the Non-Profit Sector: The Impact Collaborative

Updated Category News Views 159

Impact Collaborative Launches to Transform the Non-Profit Sector Today marks a significant milestone with the launch of the Impact Collaborative (IC), a pioneering initiative aimed at revolutionizing the support provided to under-resourced communities. This innovative approach seeks to disrupt generational poverty while offering much-needed access to mental health and...

Continue Reading
Synovus Financial Corp Declares Quarterly Dividends for Investors

Updated Category News Views 128

Synovus Financial Corp Declares Quarterly Dividends Synovus Financial Corp. (NYSE: SNV) has recently revealed the details of its latest quarterly dividends. The board of directors has approved significant payouts to its shareholders, reinforcing the company’s ongoing commitment to deliver value to its investors. Details of the Declared Dividends The following dividends...

Continue Reading
Walnut Hill Medical Enhances Patient Access Through FDA TAP Program

Updated Category News Views 171

Walnut Hill Medical Partners with FDA in TAP Program Walnut Hill Medical, a prominent healthcare consultancy known for its market access and reimbursement strategies, has been chosen as an advisor to the FDA's Total Product Life Cycle Advisory Program (TAP). This initiative, which originated from the FDA's Center for Devices and Radiological Health (CDRH), aims to improve...

Continue Reading